Jinhe Biotechnology announced that the company has received Document No. 839 from the Ministry of Agriculture. In accordance with the Regulations on the Administration of Veterinary Medicines and the Measures for the Registration of Veterinary Medicines, the company's application for the registration change of the oxytetracycline premix veterinary drug product has been reviewed and approved, and the revised instructions and labels have been issued. The change involves adding lambs as target animals, with a monitoring period of 3 years. The company stated that this change will expand the product's scope and market space, playing a positive role in enhancing market competitiveness, consolidating industry position, and promoting sustainable development. However, the listing and sales of the product are subject to uncertainties due to factors such as market conditions.